Anteo Diagnostics appoints new CEO

Latest News

Anteo Diagnostics (ASX:ADO) has announced the appointment of Derek Thomson as its new chief executive officer.

The company said Mr Thomson has a strong financial background and a track record in business development, team leadership, client relationship management, contract negotiation and is skilled in forming solid commercial partnerships across a range of sectors.

He has held senior roles in a range of companies, including KPMG, Cap Gemini, IBM, Oracle and Telstra.

Since 2015, he has been a Director of technology solutions innovation company ATI Solutions Group where he led the company’s operations on Australia's east coast.

The company said Mr Thomson’s skills are well aligned with its current commercial objectives in both the life sciences and energy sectors of building lasting commercial partnerships and collaborations.

“The Board has acted swiftly in securing what we believe is an excellent leader in Derek Thomson and we believe he is a strong fit for Anteo in driving the momentum we have established through our collaborations over the past 12 months," said Anteo’s non-executive chairman Dr Jack Hamilton. 

"We have had a dialogue with Derek for some time which has given us added confidence. We look forward to welcoming him to Anteo next month when he commences.”

“I am looking forward to bringing my skills to Anteo and working with the team to realise the full commercial potential of this unique technology," said Mr Thomson.

"Forming long-lasting commercial partnerships has been a key strength throughout my career and this will be an obvious focus at Anteo.

“As the incoming CEO, I am in the fortunate position of being able to lead the Company so it can capitalise on the enormous amount of research and development undertaken to date by Anteo’s exceptionally dedicated and highly capable team. This is indeed a great opportunity to unlock the full potential of Anteo’s technology.”